ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Basiliximab Injection Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-10A8860
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Basiliximab Injection Market Outlook 2022
BUY CHAPTERS

Global Basiliximab Injection Market Research Report 2025

Code: QYRE-Auto-10A8860
Report
July 2025
Pages:74
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Novartis
Ryvis Pharma

Basiliximab Injection Market

The global market for Basiliximab Injection was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Basiliximab Injection is used with other medications to prevent immediate transplant rejection (attack of the transplanted organ by the immune system of the person receiving the organ) in people who are receiving kidney transplants. Basiliximab injection is in a class of medications called immunosuppressants. It works by decreasing the activity of the body"s immune system so it will not attack the transplanted organ.
North American market for Basiliximab Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Basiliximab Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Basiliximab Injection include Novartis AG, Ryvis Pharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Basiliximab Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Basiliximab Injection.
The Basiliximab Injection market size, estimations, and forecasts are provided in terms of sales volume (KL) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Basiliximab Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Basiliximab Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Basiliximab Injection Market Report

Report Metric Details
Report Name Basiliximab Injection Market
Segment by Type
  • 20 mL
  • 10 mL
Segment by Application
  • Adult Use
  • Pediatric Use
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Novartis AG, Ryvis Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Basiliximab Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Basiliximab Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Basiliximab Injection Market report?

Ans: The main players in the Basiliximab Injection Market are Novartis AG, Ryvis Pharma

What are the Application segmentation covered in the Basiliximab Injection Market report?

Ans: The Applications covered in the Basiliximab Injection Market report are Adult Use, Pediatric Use

What are the Type segmentation covered in the Basiliximab Injection Market report?

Ans: The Types covered in the Basiliximab Injection Market report are 20 mL, 10 mL

1 Basiliximab Injection Market Overview
1.1 Product Definition
1.2 Basiliximab Injection by Type
1.2.1 Global Basiliximab Injection Market Value Comparison by Type (2024 VS 2031)
1.2.2 20 mL
1.2.3 10 mL
1.3 Basiliximab Injection by Application
1.3.1 Global Basiliximab Injection Market Value by Application (2024 VS 2031)
1.3.2 Adult Use
1.3.3 Pediatric Use
1.4 Global Basiliximab Injection Market Size Estimates and Forecasts
1.4.1 Global Basiliximab Injection Revenue 2020-2031
1.4.2 Global Basiliximab Injection Sales 2020-2031
1.4.3 Global Basiliximab Injection Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Basiliximab Injection Market Competition by Manufacturers
2.1 Global Basiliximab Injection Sales Market Share by Manufacturers (2020-2025)
2.2 Global Basiliximab Injection Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Basiliximab Injection Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Basiliximab Injection, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Basiliximab Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Basiliximab Injection, Product Type & Application
2.7 Global Key Manufacturers of Basiliximab Injection, Date of Enter into This Industry
2.8 Global Basiliximab Injection Market Competitive Situation and Trends
2.8.1 Global Basiliximab Injection Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Basiliximab Injection Players Market Share by Revenue
2.8.3 Global Basiliximab Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Basiliximab Injection Market Scenario by Region
3.1 Global Basiliximab Injection Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Basiliximab Injection Sales by Region: 2020-2031
3.2.1 Global Basiliximab Injection Sales by Region: 2020-2025
3.2.2 Global Basiliximab Injection Sales by Region: 2026-2031
3.3 Global Basiliximab Injection Revenue by Region: 2020-2031
3.3.1 Global Basiliximab Injection Revenue by Region: 2020-2025
3.3.2 Global Basiliximab Injection Revenue by Region: 2026-2031
3.4 North America Basiliximab Injection Market Facts & Figures by Country
3.4.1 North America Basiliximab Injection Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Basiliximab Injection Sales by Country (2020-2031)
3.4.3 North America Basiliximab Injection Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Basiliximab Injection Market Facts & Figures by Country
3.5.1 Europe Basiliximab Injection Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Basiliximab Injection Sales by Country (2020-2031)
3.5.3 Europe Basiliximab Injection Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Basiliximab Injection Market Facts & Figures by Region
3.6.1 Asia Pacific Basiliximab Injection Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Basiliximab Injection Sales by Region (2020-2031)
3.6.3 Asia Pacific Basiliximab Injection Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Basiliximab Injection Market Facts & Figures by Country
3.7.1 Latin America Basiliximab Injection Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Basiliximab Injection Sales by Country (2020-2031)
3.7.3 Latin America Basiliximab Injection Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Basiliximab Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Basiliximab Injection Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Basiliximab Injection Sales by Country (2020-2031)
3.8.3 Middle East and Africa Basiliximab Injection Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Basiliximab Injection Sales by Type (2020-2031)
4.1.1 Global Basiliximab Injection Sales by Type (2020-2025)
4.1.2 Global Basiliximab Injection Sales by Type (2026-2031)
4.1.3 Global Basiliximab Injection Sales Market Share by Type (2020-2031)
4.2 Global Basiliximab Injection Revenue by Type (2020-2031)
4.2.1 Global Basiliximab Injection Revenue by Type (2020-2025)
4.2.2 Global Basiliximab Injection Revenue by Type (2026-2031)
4.2.3 Global Basiliximab Injection Revenue Market Share by Type (2020-2031)
4.3 Global Basiliximab Injection Price by Type (2020-2031)
5 Segment by Application
5.1 Global Basiliximab Injection Sales by Application (2020-2031)
5.1.1 Global Basiliximab Injection Sales by Application (2020-2025)
5.1.2 Global Basiliximab Injection Sales by Application (2026-2031)
5.1.3 Global Basiliximab Injection Sales Market Share by Application (2020-2031)
5.2 Global Basiliximab Injection Revenue by Application (2020-2031)
5.2.1 Global Basiliximab Injection Revenue by Application (2020-2025)
5.2.2 Global Basiliximab Injection Revenue by Application (2026-2031)
5.2.3 Global Basiliximab Injection Revenue Market Share by Application (2020-2031)
5.3 Global Basiliximab Injection Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Novartis AG
6.1.1 Novartis AG Company Information
6.1.2 Novartis AG Description and Business Overview
6.1.3 Novartis AG Basiliximab Injection Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Novartis AG Basiliximab Injection Product Portfolio
6.1.5 Novartis AG Recent Developments/Updates
6.2 Ryvis Pharma
6.2.1 Ryvis Pharma Company Information
6.2.2 Ryvis Pharma Description and Business Overview
6.2.3 Ryvis Pharma Basiliximab Injection Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Ryvis Pharma Basiliximab Injection Product Portfolio
6.2.5 Ryvis Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Basiliximab Injection Industry Chain Analysis
7.2 Basiliximab Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Basiliximab Injection Production Mode & Process Analysis
7.4 Basiliximab Injection Sales and Marketing
7.4.1 Basiliximab Injection Sales Channels
7.4.2 Basiliximab Injection Distributors
7.5 Basiliximab Injection Customer Analysis
8 Basiliximab Injection Market Dynamics
8.1 Basiliximab Injection Industry Trends
8.2 Basiliximab Injection Market Drivers
8.3 Basiliximab Injection Market Challenges
8.4 Basiliximab Injection Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Novartis
Ryvis Pharma
List of Tables
 Table 1. Global Basiliximab Injection Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Basiliximab Injection Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Basiliximab Injection Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Basiliximab Injection Sales (KL) of Key Manufacturers (2020-2025)
 Table 5. Global Basiliximab Injection Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Basiliximab Injection Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Basiliximab Injection Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Basiliximab Injection Average Price (US$/L) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Basiliximab Injection, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Basiliximab Injection, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Basiliximab Injection, Product Type & Application
 Table 12. Global Key Manufacturers of Basiliximab Injection, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Basiliximab Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Basiliximab Injection as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Basiliximab Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Basiliximab Injection Sales by Region (2020-2025) & (KL)
 Table 18. Global Basiliximab Injection Sales Market Share by Region (2020-2025)
 Table 19. Global Basiliximab Injection Sales by Region (2026-2031) & (KL)
 Table 20. Global Basiliximab Injection Sales Market Share by Region (2026-2031)
 Table 21. Global Basiliximab Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Basiliximab Injection Revenue Market Share by Region (2020-2025)
 Table 23. Global Basiliximab Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Basiliximab Injection Revenue Market Share by Region (2026-2031)
 Table 25. North America Basiliximab Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Basiliximab Injection Sales by Country (2020-2025) & (KL)
 Table 27. North America Basiliximab Injection Sales by Country (2026-2031) & (KL)
 Table 28. North America Basiliximab Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Basiliximab Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Basiliximab Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Basiliximab Injection Sales by Country (2020-2025) & (KL)
 Table 32. Europe Basiliximab Injection Sales by Country (2026-2031) & (KL)
 Table 33. Europe Basiliximab Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Basiliximab Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Basiliximab Injection Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Basiliximab Injection Sales by Region (2020-2025) & (KL)
 Table 37. Asia Pacific Basiliximab Injection Sales by Region (2026-2031) & (KL)
 Table 38. Asia Pacific Basiliximab Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Basiliximab Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Basiliximab Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Basiliximab Injection Sales by Country (2020-2025) & (KL)
 Table 42. Latin America Basiliximab Injection Sales by Country (2026-2031) & (KL)
 Table 43. Latin America Basiliximab Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Basiliximab Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Basiliximab Injection Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Basiliximab Injection Sales by Country (2020-2025) & (KL)
 Table 47. Middle East and Africa Basiliximab Injection Sales by Country (2026-2031) & (KL)
 Table 48. Middle East and Africa Basiliximab Injection Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Basiliximab Injection Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Basiliximab Injection Sales (KL) by Type (2020-2025)
 Table 51. Global Basiliximab Injection Sales (KL) by Type (2026-2031)
 Table 52. Global Basiliximab Injection Sales Market Share by Type (2020-2025)
 Table 53. Global Basiliximab Injection Sales Market Share by Type (2026-2031)
 Table 54. Global Basiliximab Injection Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Basiliximab Injection Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Basiliximab Injection Revenue Market Share by Type (2020-2025)
 Table 57. Global Basiliximab Injection Revenue Market Share by Type (2026-2031)
 Table 58. Global Basiliximab Injection Price (US$/L) by Type (2020-2025)
 Table 59. Global Basiliximab Injection Price (US$/L) by Type (2026-2031)
 Table 60. Global Basiliximab Injection Sales (KL) by Application (2020-2025)
 Table 61. Global Basiliximab Injection Sales (KL) by Application (2026-2031)
 Table 62. Global Basiliximab Injection Sales Market Share by Application (2020-2025)
 Table 63. Global Basiliximab Injection Sales Market Share by Application (2026-2031)
 Table 64. Global Basiliximab Injection Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Basiliximab Injection Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Basiliximab Injection Revenue Market Share by Application (2020-2025)
 Table 67. Global Basiliximab Injection Revenue Market Share by Application (2026-2031)
 Table 68. Global Basiliximab Injection Price (US$/L) by Application (2020-2025)
 Table 69. Global Basiliximab Injection Price (US$/L) by Application (2026-2031)
 Table 70. Novartis AG Company Information
 Table 71. Novartis AG Description and Business Overview
 Table 72. Novartis AG Basiliximab Injection Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 73. Novartis AG Basiliximab Injection Product
 Table 74. Novartis AG Recent Developments/Updates
 Table 75. Ryvis Pharma Company Information
 Table 76. Ryvis Pharma Description and Business Overview
 Table 77. Ryvis Pharma Basiliximab Injection Sales (KL), Revenue (US$ Million), Price (US$/L) and Gross Margin (2020-2025)
 Table 78. Ryvis Pharma Basiliximab Injection Product
 Table 79. Ryvis Pharma Recent Developments/Updates
 Table 80. Key Raw Materials Lists
 Table 81. Raw Materials Key Suppliers Lists
 Table 82. Basiliximab Injection Distributors List
 Table 83. Basiliximab Injection Customers List
 Table 84. Basiliximab Injection Market Trends
 Table 85. Basiliximab Injection Market Drivers
 Table 86. Basiliximab Injection Market Challenges
 Table 87. Basiliximab Injection Market Restraints
 Table 88. Research Programs/Design for This Report
 Table 89. Key Data Information from Secondary Sources
 Table 90. Key Data Information from Primary Sources
 Table 91. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Basiliximab Injection
 Figure 2. Global Basiliximab Injection Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Basiliximab Injection Market Share by Type: 2024 & 2031
 Figure 4. 20 mL Product Picture
 Figure 5. 10 mL Product Picture
 Figure 6. Global Basiliximab Injection Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Basiliximab Injection Market Share by Application: 2024 & 2031
 Figure 8. Adult Use
 Figure 9. Pediatric Use
 Figure 10. Global Basiliximab Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Basiliximab Injection Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Basiliximab Injection Sales (2020-2031) & (KL)
 Figure 13. Global Basiliximab Injection Average Price (US$/L) & (2020-2031)
 Figure 14. Basiliximab Injection Report Years Considered
 Figure 15. Basiliximab Injection Sales Share by Manufacturers in 2024
 Figure 16. Global Basiliximab Injection Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Basiliximab Injection Players: Market Share by Revenue in Basiliximab Injection in 2024
 Figure 18. Basiliximab Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Basiliximab Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Basiliximab Injection Sales Market Share by Country (2020-2031)
 Figure 21. North America Basiliximab Injection Revenue Market Share by Country (2020-2031)
 Figure 22. United States Basiliximab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Basiliximab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Basiliximab Injection Sales Market Share by Country (2020-2031)
 Figure 25. Europe Basiliximab Injection Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Basiliximab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Basiliximab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Basiliximab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Basiliximab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Basiliximab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Basiliximab Injection Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Basiliximab Injection Revenue Market Share by Region (2020-2031)
 Figure 33. China Basiliximab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Basiliximab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Basiliximab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Basiliximab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Basiliximab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Basiliximab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Indonesia Basiliximab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Thailand Basiliximab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Malaysia Basiliximab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Basiliximab Injection Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Basiliximab Injection Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Basiliximab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Basiliximab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Basiliximab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Basiliximab Injection Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Basiliximab Injection Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Basiliximab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Basiliximab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Basiliximab Injection Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Basiliximab Injection by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Basiliximab Injection by Type (2020-2031)
 Figure 54. Global Basiliximab Injection Price (US$/L) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Basiliximab Injection by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Basiliximab Injection by Application (2020-2031)
 Figure 57. Global Basiliximab Injection Price (US$/L) by Application (2020-2031)
 Figure 58. Basiliximab Injection Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Drug for Organ Rejection Prophylaxis Market Research Report 2025
Global Organ Transplant Immunosuppressant Market Research Report 2024
Global Infliximab Injection Market Research Report 2024
Global Cyclosporine Drugs Market Research Report 2025
Tacrolimus Injection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Immunosuppressants Market Research Report 2024
Global Selective Immunosuppressants Market Research Report 2024
Organ Transplant Anti rejection Medications Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Organ Transplant Immunosuppressant Drugs Market Insights Forecast to 2030
Global Tacrolimus Capsules Market Research Report 2024
Global Ampicillin Injection Market Research Report 2025
Global Immunosuppressive Therapy for Eye Diseases Market Research Report 2024
Global Ocular Immunosuppresent Market Research Report 2024
Global Immunosuppressive Drugs for Ocular Inflammation Market Research Report 2024
Global Ocular Immunosuppresents Market Research Report 2024
Global Organ Transplant Rejection Medicine Market Research Report 2025
Global Cytomegalovirus Immune Globulin Intravenous Human CMV IGIV Market Research Report 2024
Global Ocular Immunosuppressants Market Research Report 2024
Organ Transplant Rejection Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Fujimycin Market Insights Forecast to 2030

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19B19893
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30B3636
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3H1702
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13C3384
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions